Rho(D) immune globulin
Prevention of Rh immunization in Rh-negative women, Prevention of Rh immunization after incompatible transfusion
Indications
- Prevention of Rh immunization in Rh-negative women
- Prevention of Rh immunization after incompatible transfusion
Adult dosing
- antepartum 26 28 weeks: dose: 300; unit: mcg; route: IM; interval: single dose at 26-28 weeks; repeat postpartum within 72 h if newborn Rh-positive; fixed: true; labelExcerpt: RhoGAM (300 µg) (1500 IU) Postpartum (if the newborn is Rh-positive) Administer within 72 hour
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Rh-positive individuals
- History of anaphylactic reaction to human immune globulin
Clinical pearls
- Administer by intramuscular injection only.
- Observe patients for at least 20 minutes following administration.
- Monitor patients treated for incompatible transfusion for signs of hemolytic reaction.
- May cause positive serological testing results due to passively transferred antibodies.
Source and review
- DailyMed label (human rho(d) immune globulin, RhoGAM Ultra-Filtered PLUS), Set ID d87e4d0b-2442-4135-b3f9-5c4f74845b87, effective 2025-07-24. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties